증권사 리포트&코멘트05.29 13:38
AbbVie, BPDCN ADC ‘Decnupaz’ FDA 승인 획득
#남성
Endpoints News
AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchase
AbbVie said the FDA has approved an antibody-drug conjugate it obtained as a part of its $10.1 billion buyout of ImmunoGen for an ultra-rare but aggressive form of blood cancer.
bioksm ↗